Figure 17. External validation studies of Framingham risk scores by baseline date of test population excluding studies of diabetics.

Figure 17External validation studies of Framingham risk scores by baseline date of test population excluding studies of diabetics

Sensitivity analysis excluding studies with explicit sources of heterogeneity

Score refers to Abbott 1987 as modified by Grover 1992 (Abbo), Anderson 1991 (Ander), Liao 1999 (Liao), Thomsen 2002 (Thoms), Truett 1967 (Truet) and Wilson 1998 (Wilso)

From: External validation of cardiovascular risk scores to evaluate the generalisability of risk scoring methods in different populations

Cover of A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement)
A Systematic Review of Risk Scoring Methods and Clinical Decision Aids Used in the Primary Prevention of Coronary Heart Disease (Supplement) [Internet].
NICE Clinical Guidelines, No. 67S.
Beswick AD, Brindle P, Fahey T, et al.
Copyright © 2008, Royal College of General Practitioners.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.